We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSGP icon
451
CoStar Group
CSGP
$12.8B
$6.86M 0.03%
367,200
+350,000
+2,035% +$6.6M
EIX icon
452
Edison International
EIX
$21B
$6.83M 0.03%
120,592
+1,200
+1% +$59.8K
XYL icon
453
Xylem
XYL
$25.1B
$6.82M 0.03%
+187,200
New +$6.83M
SEM
454
DELISTED
Select Medical
SEM
$6.74M 0.03%
1,004,391
-85,933
-8% -$521K
PODD icon
455
Insulet
PODD
$9.66B
$6.73M 0.03%
141,885
+4,384
+3% +$194K
JAH
456
DELISTED
JARDEN CORPORATION
JAH
$6.69M 0.03%
167,625
-19,350
-10% -$786K
TPR icon
457
Tapestry
TPR
$23.3B
$6.66M 0.03%
134,003
-40,821
-23% -$2.03M
CSGS
458
DELISTED
CSG Systems International
CSGS
$6.63M 0.03%
254,814
+10,931
+4% +$308K
MYGN icon
459
Myriad Genetics
MYGN
$371M
$6.63M 0.03%
194,062
-54,905
-22% -$1.7M
TEX icon
460
Terex
TEX
$6.68B
$6.62M 0.03%
149,500
+46,000
+44% +$1.93M
AVB
461
DELISTED
AvalonBay Communities
AVB
$6.57M 0.03%
50,000
+18,000
+56% +$2.27M
VAR
462
DELISTED
Varian Medical Systems, Inc.
VAR
$6.5M 0.03%
88,197
+2,859
+3% +$206K
AMAT icon
463
Applied Materials
AMAT
$334B
$6.46M 0.03%
316,559
+71,459
+29% +$1.31M
FCX icon
464
Freeport-McMoran
FCX
$99.6B
$6.44M 0.03%
194,876
-3,424
-2% -$114K
BAH icon
465
Booz Allen Hamilton
BAH
$9.63B
$6.43M 0.03%
292,230
+9,527
+3% +$190K
AMD icon
466
Advanced Micro Devices
AMD
$823B
$6.4M 0.03%
1,595,500
+244,400
+18% +$933K
NWL icon
467
Newell Brands
NWL
$2.4B
$6.37M 0.03%
213,050
-134,100
-39% -$4.16M
CLR
468
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$6.33M 0.03%
101,926
+10,000
+11% +$570K
IEO icon
469
iShares US Oil & Gas Exploration & Production ETF
IEO
$746M
$6.32M 0.03%
74,350
+3,060
+4% +$249K
EWI icon
470
iShares MSCI Italy ETF
EWI
$1.1B
$6.29M 0.03%
177,474
RKT
471
DELISTED
ROCK-TENN COMPANY CL-A
RKT
$6.22M 0.03%
117,880
-260,600
-69% -$13.6M
MMP
472
DELISTED
Magellan Midstream Partners, L.P.
MMP
$6.21M 0.03%
89,000
IMO icon
473
Imperial Oil
IMO
$65.4B
$6.13M 0.03%
131,342
-6,300
-5% -$275K
EW icon
474
Edwards Lifesciences
EW
$49.4B
$6.05M 0.03%
489,696
+7,404
+2% +$85.4K
NUVA
475
DELISTED
NuVasive, Inc.
NUVA
$6M 0.03%
156,271
+5,074
+3% +$186K

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.